TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-08-28
DOI
10.3389/fimmu.2019.02044
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
- (2019) Mohammed Alnaggar et al. Journal for ImmunoTherapy of Cancer
- Regulatory functions of γδ T cells
- (2018) Christian Peters et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Regulatory Role of G Protein-coupled Receptors in Pancreatic Cancer Development and Progression
- (2018) Hildegard M. Schuller CURRENT MEDICINAL CHEMISTRY
- Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells
- (2018) Hans H. Oberg et al. Frontiers in Immunology
- Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC
- (2018) Jan-Paul Gundlach et al. BMC CANCER
- γδ cells and tumor microenvironment: A helpful or a dangerous liason?
- (2017) Elena Lo Presti et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity
- (2017) Guranda Chitadze et al. TRENDS IN IMMUNOLOGY
- Current Advances in γδ T Cell-Based Tumor Immunotherapy
- (2017) Elena Lo Presti et al. Frontiers in Immunology
- CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1
- (2016) Y. Lee et al. CLINICAL CANCER RESEARCH
- Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer
- (2016) Sourav Paul et al. INTERNATIONAL JOURNAL OF CANCER
- Monitoring and functional characterization of the lymphocytic compartment in pancreatic ductal adenocarcinoma patients
- (2016) Hans-Heinrich Oberg et al. PANCREATOLOGY
- TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress
- (2016) Florent Dufour et al. Oncotarget
- Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic
- (2015) Emmanouil Fokas et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Cancer Cell-Autonomous TRAIL-R Signaling Promotes KRAS-Driven Cancer Progression, Invasion, and Metastasis
- (2015) Silvia von Karstedt et al. CANCER CELL
- γδ T cell activation by bispecific antibodies
- (2015) Hans-Heinrich Oberg et al. CELLULAR IMMUNOLOGY
- Blinatumomab: First Global Approval
- (2015) Mark Sanford DRUGS
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity
- (2015) L O'Leary et al. ONCOGENE
- Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity
- (2015) Daniel Gonnermann et al. OncoImmunology
- Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells
- (2015) Baolin Zhang et al. Oncotarget
- Novel Bispecific Antibodies Increase T-Cell Cytotoxicity against Pancreatic Cancer Cells
- (2014) H.-H. Oberg et al. CANCER RESEARCH
- Getting TRAIL back on track for cancer therapy
- (2014) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies
- (2014) Mohsen Vosooghi et al. Expert Opinion on Drug Discovery
- Dominant Negative Effects of Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL) Receptor 4 on TRAIL Receptor 1 Signaling by Formation of Heteromeric Complexes
- (2014) Simon Neumann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
- (2014) Martin Wilhelm et al. Journal of Translational Medicine
- Comparative Characterization of Stroma Cells and Ductal Epithelium in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
- (2014) Ole Helm et al. PLoS One
- Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis
- (2014) M. Lu et al. SCIENCE
- Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
- (2014) U Bertsch et al. Cell Death & Disease
- Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
- (2014) Hans-Heinrich Oberg et al. Frontiers in Immunology
- Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment
- (2014) Elena Lo Presti et al. Frontiers in Immunology
- Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy
- (2014) Jonathan Fisher et al. OncoImmunology
- Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family
- (2013) K Azijli et al. CELL DEATH AND DIFFERENTIATION
- NKG2D regulates production of soluble TRAIL by ex vivo expanded human γδ T cells
- (2013) Pouneh Dokouhaki et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- An unconventional TRAIL to cancer therapy
- (2013) Hung-Chang Chen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Nuclear Death Receptor TRAIL-R2 Inhibits Maturation of Let-7 and Promotes Proliferation of Pancreatic and Other Tumor Cells
- (2013) Verena Haselmann et al. GASTROENTEROLOGY
- Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17
- (2013) Guranda Chitadze et al. INTERNATIONAL JOURNAL OF CANCER
- CD1d-lipid antigen recognition by the γδ TCR
- (2013) Adam P Uldrich et al. NATURE IMMUNOLOGY
- Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human T-cell subset
- (2012) C. Harly et al. BLOOD
- Prostaglandin E2 and T cells: friends or foes?
- (2011) Vinatha Sreeramkumar et al. IMMUNOLOGY AND CELL BIOLOGY
- Importin β1 Protein-mediated Nuclear Localization of Death Receptor 5 (DR5) Limits DR5/Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Cell Death of Human Tumor Cells
- (2011) Yuko Kojima et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT
- (2011) Najoua Lalaoui et al. PLoS One
- Crystal structure of a T-cell receptor specific for the human MHC class I homolog MICA
- (2011) B. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling
- (2010) Ludovic Martinet et al. BIOCHEMICAL PHARMACOLOGY
- In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
- (2010) S. Meraviglia et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Expression, Cellular Distribution, and Prognostic Relevance of TRAIL Receptors in Hepatocellular Carcinoma
- (2010) L. Kriegl et al. CLINICAL CANCER RESEARCH
- Oncogenic K-Ras Turns Death Receptors Into Metastasis-Promoting Receptors in Human and Mouse Colorectal Cancer Cells
- (2010) Frederik J.H. Hoogwater et al. GASTROENTEROLOGY
- TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5
- (2010) Johannes Lemke et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human T Cells
- (2009) H. Shojaei et al. CANCER RESEARCH
- Prognostic Value of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and TRAIL Receptors in Renal Cell Cancer
- (2009) S. Macher-Goeppinger et al. CLINICAL CANCER RESEARCH
- A regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells
- (2009) Ludovic Martinet et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Efficient Killing of Human Colon Cancer Stem Cells by T Lymphocytes
- (2009) M. Todaro et al. JOURNAL OF IMMUNOLOGY
- Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer
- (2009) Tom M. Ganten et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- High TRAIL Death Receptor 4 and Decoy Receptor 2 Expression Correlates With Significant Cell Death in Pancreatic Ductal Adenocarcinoma Patients
- (2009) Ahter Dilsad Sanlioglu et al. PANCREAS
- Gemcitabine Plus Celecoxib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
- (2008) Tomislav Dragovich et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
- (2008) S. Yagyu et al. CLINICAL CANCER RESEARCH
- Zoledronate facilitates large-scale ex vivo expansion of functional γδ T cells from cancer patients for use in adoptive immunotherapy*
- (2008) M. Kondo et al. CYTOTHERAPY
- Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human γδ-T cells: Implications in the design of γδ-T-cell-based immunotherapies for pancreatic cancer
- (2008) Zhiyong Liu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
- Selective Inhibition of Cyclooxygenase-2 Suppresses the Growth of Pancreatic Cancer Cells in Vitro and in Vivo
- (2008) Xuan-Fu Xu et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma
- (2007) Ismail T. Koksal et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started